Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Montelukast + Levocetirizine bulk supplier for pharma manufacturers

Montelukast + Levocetirizine Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Montelukast (10 mg) + Levocetirizine (5 mg)

Reference Brands: Levocet-M, Montel-LC, Combizar(EU)

Category: Allergy Medication

Montelukast 10 mg + Levocetirizine 5 mg tablets provide effective relief from allergic rhinitis and urticaria, combining antihistamine and anti-inflammatory action. Marketed as Montel-LC, Levocet-M, and generics, it's ideal for EU and US pharma markets.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Montelukast + Levocetirizine? List it or send an offer →

Product Description:

Montelukast Sodium 10 mg and Levocetirizine Hydrochloride 5 mg tablets offer dual-action relief from allergic rhinitis, chronic urticaria, and seasonal allergies. This fixed-dose combination provides antihistamine and anti-inflammatory effects, ideal for patients with respiratory and nasal symptoms. Marketed under brands like Montel-LC, Levocet-M, and various generics, it is approved for use across regulated EU and US markets. We offer GMP-certified, FDA-compliant formulations for bulk export, private labeling, and hospital or pharmacy distribution.

Montelukast + Levocetirizine — third party manufacturing & bulk supply

Montelukast + Levocetirizine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Montelukast + Levocetirizine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Montelukast + Levocetirizine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Montelukast + Levocetirizine →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Montelukast and Levocetirizine are used together to treat symptoms of allergic rhinitis (such as sneezing, runny or itchy nose, and watery eyes) and to help manage mild asthma. This combination works by blocking two different allergic response pathways — montelukast blocks leukotrienes that cause airway inflammation and tightening, while levocetirizine blocks histamine, which causes itching, sneezing, and runny nose. Together, they provide more complete relief from allergy and breathing symptoms.

This combination contains two active ingredients: montelukast sodium, a leukotriene receptor antagonist, and levocetirizine dihydrochloride, a non-sedating antihistamine. Inactive ingredients may include lactose monohydrate, microcrystalline cellulose, magnesium stearate, and other excipients depending on the tablet formulation.

The most common trade names for this combination are Montair-LC, Telekast-L, and Levomont, which are widely available in India and several other countries.

This combination is manufactured by several pharmaceutical companies including Cipla, Sun Pharma, Lupin, Dr. Reddy’s Laboratories, and Mankind Pharma, among others.

The generic name of the combination is montelukast sodium and levocetirizine dihydrochloride.

Brand names include Montair-LC, Telekast-L, Levomont, and Montecip-LC, depending on the manufacturer and market.

Montelukast and Levocetirizine combination tablets are mainly manufactured in India by pharmaceutical companies such as Cipla, Sun Pharma, Lupin, and Dr. Reddy’s Laboratories, and are exported to several international markets across Asia, Africa, and the Middle East.

Related Products

Adrenaline

Strength:
0.3 mg, 0.15 mg

Form: Auto Injector & Prefilled syringe

Reference Brands: EpiPen(US & EU); Auvi-Q, Symjepi(US); Emerade, Jext, Anapen(EU)

View Details
Phenylephrine Chlorpheniramine

Strength:
Phenylephrine(2.5 mg) + Chlorpheniramine(1 mg)per 5 mL

Form: Syrup

Reference Brands: Dimetapp Cold & Allergy(US); Chlorpe-P(EU)

View Details
Promethazine

Strength:
Rectal Suppo. & Tablets(12.5 mg, 25 mg, 50 mg); Injection(25 mg/mL, 50 mg/mL)

Form: Tablet, Injection & Rectal suppositories

Reference Brands: Phenergan, Promethegan, Phenergan Injection(US & EU)

View Details
Olopatadine

Strength:
0.1%, 0.2% & 0.7%

Form: Eye Drops

Reference Brands: Patanol(US & EU); Pataday(US); Opatanol(EU)

View Details
Oxymetazoline

Strength:
0.025%, 0.05%, 0.1%

Form: Nasal Drops

Reference Brands: Afrin®, Dristan®, Zicam®(US); Nasivin®, Vicks Sinex®(EU)

View Details
Montelukast Sodium Tablets

Strength:
Tablets:10 mg; Chewable Tablets: 4 mg / 5 mg; Oral Granules:4 mg (sachet)

Form: Tablets, Chewable Tablets, Oral Granules

Reference Brands: Singulair®, Montelukast Teva(US & EU)

View Details
Desloratadine

Strength:
Tab: 5 mg; syrup: 0.5 mg/mL or 2.5 mg/5 mL

Form: Tablets & Syrup

Reference Brands: Clarinex® (US); Aerius®, Desloratadine Teva(EU)

View Details
Hydrocortisone Sodium Succinate

Strength:
100 mg, 250 mg, 500 mg, 1 g

Form: Powder for reconstitution (IV/IM use)

Reference Brands: Solu-Cortef®(Eu & US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us